Onward Medical N.V. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 2.1 million compared to EUR 1.4 million a year ago. Net loss was EUR 32.8 million compared to EUR 34.3 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 EUR | +1.08% | -7.68% | +51.29% |
Apr. 25 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 02 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+51.29% | 173M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- ONWD Stock
- News Onward Medical N.V.
- Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2022